Commercial teams need an easy and reliable way to determine what portion of a product's sales or percentage of prescriptions are associated with a specific diagnosis. The ability to understand and evaluate the diagnosis market and new indication potential for existing products, combined with the ability to assess multi-indication product performance, is vital to long-term commercial success.
IQVIA drives customers to new levels of Connected Intelligence™ with Diagnosis Allocation. Diagnosis Allocation provides visibility to National Sales Perspectives (NSP) sales and National Prescription Audit (NPA) prescriptions by diagnosis and offers advantages in coverage granularity, and reporting leads to improved insights.
Read the fact sheet to learn more.